CSIMarket

Company Name or Ticker Symbol

Search for oher Categories

Healthcare Sector

Major Pharmaceutical Preparations Industry Profitability

Profitability by Company within Major Pharmaceutical Preparations Industry
Company	Quarter	Gross Margin	Net Margin	Cash flow Margin	ROE
Abeona Therapeutics Inc.	2 Q	-	-	-	-
Abbott Laboratories	2 Q	57.74 %	9.44 %	-	2.95 %
Arbutus Biopharma Corp	2 Q	-	-	-	-
Acadia Pharmaceuticals Inc	1 Q	92.87 %	-	-	-
Achillion Pharmaceuticals Inc	2 Q	-	-	-	-
Acelrx Pharmaceuticals Inc	2 Q	8.44 %	-	-	-
Acura Pharmaceuticals, Inc	2 Q	-	-	-	-
Alcobra Ltd.	0 Q	-	-	-	-
Adamis Pharmaceuticals Corp	2 Q	38.93 %	-	-	-
Adamas Pharmaceuticals Inc	2 Q	99.04 %	-	-	-
Aduro Biotech, Inc.	2 Q	-	-	-	-
Advaxis, Inc.	2 Q	-	-	-	-
Aegerion Pharmaceuticals, Inc.	0 Q	-	-	-	-
Agios Pharmaceuticals Inc	1 Q	-	-	-	-
Aeglea Biotherapeutics, Inc.	2 Q	-	-	-	-
Agile Therapeutics Inc	2 Q	-	-	-	-
Aimmune Therapeutics, Inc.	1 Q	-	-	-	-
Achaogen Inc	2 Q	-	-	-	-
Akebia Therapeutics, Inc.	1 Q	-	-	-	-
Akorn Inc	2 Q	42.57 %	-	-	-
Albireo Pharma, Inc.	2 Q	-	-	-	-
Aldeyra Therapeutics, Inc.	2 Q	-	-	-	-
Alimera Sciences Inc	2 Q	89.8 %	-	-	-
Alkermes Plc.	2 Q	85.75 %	-	1.57 %	-
Alnylam Pharmaceuticals, Inc.	2 Q	-	-	-	-
Alpine Immune Sciences, Inc.	2 Q	-	-	-	-
Alexza Pharmaceuticals Inc.	0 Q	-	-	-	-
Alexion Pharmaceuticals, Inc.	2 Q	90.88 %	-	-	-
Amag Pharmaceuticals Inc.	2 Q	47.51 %	-	-	-
Amylin Pharmaceuticals Inc	0 Q	-	-	-	-
Ampio Pharmaceuticals, Inc.	2 Q	-	-	-	-
Amphastar Pharmaceuticals, Inc.	2 Q	36.82 %	-	-	-
Amarin Corp Plcuk	2 Q	75.6 %	-	-	-
Anacor Pharmaceuticals, Inc.	0 Q	-	-	-	-
Ani Pharmaceuticals Inc	2 Q	64.9 %	5.88 %	-	0.07 %
Antriabio, Inc.	3 Q	-	-	-	-
Anthera Pharmaceuticals Inc	1 Q	-	-	-	-
Apellis Pharmaceuticals, Inc.	2 Q	-	-	-	-
Apricus Biosciences, Inc.	2 Q	-	-	-	-
Aquinox Pharmaceuticals, Inc	2 Q	-	11.67 %	-	-
Ardelyx, Inc.	2 Q	-	-	-	-
Argos Therapeutics Inc	2 Q	-	-	-	-
Aralez Pharmaceuticals Inc.	1 Q	69.71 %	-	39.86 %	-
Arena Pharmaceuticals Inc	2 Q	-	-	-	-
Arqule Inc	2 Q	-	37.62 %	46.55 %	-
Array Biopharma Inc	2 Q	54.32 %	-	-	-
Athersys, Inc	2 Q	-	-	18.98 %	-
Actinium Pharmaceuticals, Inc.	2 Q	-	-	-	-
Athenex, Inc.	2 Q	18.35 %	-	4.71 %	-
Avenue Therapeutics, Inc.	2 Q	-	-	-	-
Nuo Therapeutics, Inc.	2 Q	72.36 %	-	-	-
Avadel Pharmaceuticals Plc	2 Q	87.98 %	-	-	-
Aveo Pharmaceuticals Inc	2 Q	-	-	-	-
Aoxing Pharmaceutical Company, Inc.	1 Q	77.53 %	2.52 %	4.06 %	-
Axsome Therapeutics, Inc.	1 Q	-	-	-	-
Astrazeneca Plc	2 Q	44.56 %	3.43 %	-	-
Biodelivery Sciences International Inc	2 Q	62.5 %	-	-	-
Beigene, Ltd.	2 Q	88.15 %	-	-	-
Dnib Unwind, Inc.	0 Q	-	-	-	-
Biodel Inc	0 Q	-	-	-	-
Bellicum Pharmaceuticals, Inc.	2 Q	65.68 %	-	-	-
Bellerophon Therapeutics, Inc.	2 Q	-	-	-	-
Biolinerx Ltd.	2 Q	-	-	-	-
Biomarin Pharmaceutical Inc	2 Q	78.81 %	-	-	-
Bristol Myers Squibb Co	2 Q	71.51 %	6.7 %	-	3.1 %
Fitlife Brands, Inc.	0 Q	-	-	-	-
Blueprint Medicines Corp	2 Q	-	-	-	-
Biostar Pharmaceuticals, Inc.	3 Q	-	-	-	2.58 %
Biospecifics Technologies Corp	2 Q	-	60.6 %	5.66 %	17.55 %
Baxalta Inc	0 Q	-	-	-	-
Beyondspring Inc.	1 Q	-	-	-	-
Calithera Biosciences, Inc.	2 Q	-	-	-	-
Can-fite Biopharma Ltd.	2 Q	-	-	-	-
Catabasis Pharmaceuticals Inc	2 Q	-	-	-	-
Cymabay Therapeutics, Inc.	2 Q	-	-	-	-
Cambrex Corp	2 Q	42.61 %	26.58 %	-	21.61 %
Columbia Laboratories Inc	0 Q	-	-	-	-
Carbylan Therapeutics, Inc.	0 Q	-	-	-	-
Chemocentryx, Inc.	2 Q	-	-	63.04 %	39.31 %
Celgene Corp	2 Q	96.7 %	27.4 %	-	-
Chembio Diagnostics, Inc.	2 Q	31.94 %	-	-	-
Cempra, Inc.	3 Q	-	-	-	-
Cerulean Pharma Inc.	4 Q	-	-	-	-
Ceres Ventures, Inc.	0 Q	-	-	-	-
Contrafect Corp	2 Q	-	-	-	-
Chiasma, Inc	2 Q	-	-	-	-
China Pharma Holdings, Inc.	0 Q	-	-	-	-
Checkpoint Therapeutics, Inc.	2 Q	-	-	-	-
Colucid Pharmaceuticals, Inc.	0 Q	-	-	-	-
Cellectar Biosciences, Inc.	2 Q	-	-	-	-
Clearside Biomedical, Inc.	1 Q	-	-	-	-
Celsion Corp	2 Q	-	-	-	-
Clovis Oncology, Inc.	2 Q	81.1 %	-	-	-
Chimerix Inc	2 Q	-	-	-	-
Conatus Pharmaceuticals Inc.	2 Q	-	-	-	-
Concert Pharmaceuticals, Inc.	2 Q	-	-	-	56.37 %
Coronado Biosciences Inc	0 Q	-	-	-	-
Global Green Inc.	0 Q	-	-	-	-
Collegium Pharmaceutical, Inc	1 Q	32.38 %	-	-	-
Corium International, Inc.	2 Q	23.78 %	-	-	-
Corcept Therapeutics Inc	2 Q	98.15 %	29.2 %	-	80.29 %
China Pharma Holdings, Inc.	2 Q	18.26 %	-	-	-
Cumberland Pharmaceuticals Inc	4 Q	83.96 %	-	29.45 %	-
Catalyst Pharmaceuticals, Inc.	2 Q	-	-	-	-
Corbus Pharmaceuticals Holdings, Inc.	1 Q	-	-	-	-
Cormedix Inc.	4 Q	-	-	-	-
Cardiome Pharma Corp	4 Q	71.78 %	-	-	-
Crispr Therapeutics Ag	0 Q	-	-	-	-
Corvus Pharmaceuticals, Inc.	2 Q	-	-	-	-
Cti Biopharma Corp.	2 Q	4.08 %	-	-	-
Catalent, Inc.	2 Q	34.06 %	12.07 %	2.73 %	7.96 %
Contravir Pharmaceuticals, Inc.	2 Q	-	-	-	-
Cyclacel Pharmaceuticals, Inc.	2 Q	-	-	-	-
China Yct International Group, Inc.	2 Q	42.72 %	22.15 %	12.01 %	12.09 %
Cymabay Therapeutics, Inc.	0 Q	-	-	-	-
Cytokinetics Inc	2 Q	-	-	-	-
Dara Biosciences, Inc.	0 Q	-	-	-	-
Depomed Inc	1 Q	90.62 %	26.34 %	-	-
Dermira, Inc.	2 Q	-	-	-	-
Pronai Therapeutics Inc	0 Q	-	-	-	-
Dipexium Pharmaceuticals, Inc.	0 Q	-	-	-	-
Dicerna Pharmaceuticals Inc	1 Q	-	-	-	-
Durect Corp	2 Q	68.24 %	-	-	-
Dynavax Technologies Corp	2 Q	-	-	-	-
Eleven Biotherapeutics, Inc.	1 Q	-	-	-	-
Endocyte Inc	2 Q	-	-	-	-
Egalet Corp	2 Q	92.87 %	-	-	-
Eagle Pharmaceuticals, Inc.	2 Q	76.26 %	4.48 %	7.72 %	12.51 %
Elite Pharmaceuticals Inc	2 Q	27.28 %	-	-	-
Emisphere Technologies Inc	1 Q	78.83 %	-	-	-
Endo International Plc	2 Q	46.56 %	-	-	-
Enanta Pharmaceuticals Inc	2 Q	-	35.43 %	-	24.68 %
Epirus Biopharmaceuticals, Inc.	0 Q	-	-	-	-
Epizyme, Inc.	2 Q	-	-	-	-
Esperion Therapeutics, Inc.	2 Q	-	-	-	-
Evoke Pharma Inc	2 Q	-	-	-	-
Eyegate Pharmaceuticals Inc	2 Q	-	-	-	-
Fortress Biotech, Inc.	2 Q	94.77 %	-	-	-
Fibrocell Science, Inc.	2 Q	-	-	-	-
Fibrogen Inc	2 Q	-	-	33.33 %	-
Flex Pharma, Inc.	2 Q	39.48 %	-	-	-
Flamel Technologies Sa	0 Q	-	-	-	-
Flexion Therapeutics Inc	2 Q	75.09 %	-	-	-
Fresenius Medical Care Ag & Co. Kgaa	2 Q	18.31 %	14.81 %	-	-
Antriabio, Inc.	0 Q	-	-	-	-
Amicus Therapeutics Inc	2 Q	85.29 %	-	-	-
Five Prime Therapeutics Inc	1 Q	-	-	-	-
Fitlife Brands, Inc.	2 Q	41.24 %	3.88 %	8.57 %	-
Futureworld Corp.	0 Q	-	-	-	-
Galectin Therapeutics Inc	2 Q	-	-	-	-
Globeimmune Inc	0 Q	-	-	-	-
Gb Sciences Inc	1 Q	68.07 %	-	-	-
Global Blood Therapeutics, Inc.	2 Q	-	-	-	-
Gemphire Therapeutics Inc.	2 Q	-	-	-	-
Geron Corp	2 Q	-	-	-	-
Guardion Health Sciences, Inc.	2 Q	60.24 %	-	-	-
Galmed Pharmaceuticals Ltd.	2 Q	-	-	-	35.54 %
Galapagos Nv	2 Q	-	-	-	-
Glycomimetics Inc	2 Q	-	-	-	-
Generex Biotechnology Corp	4 Q	-	-	-	-
Genspera Inc	0 Q	-	-	-	-
Genvec Inc	1 Q	-	-	-	-
Global Green Inc.	0 Q	-	-	-	-
Hutchison China Meditech Ltd	2 Q	29.66 %	-	-	-
Heron Therapeutics, Inc.	1 Q	72.91 %	-	-	-
HOSPIRA, INC.	0 Q	-	-	-	-
Heat Biologics, Inc.	2 Q	-	-	-	-
Horizon Pharma Plc	1 Q	43.1 %	-	58.46 %	-
Imagenetix Inc	0 Q	-	-	-	-
Iaso Biomed, Inc.	2 Q	-	-	-	-
Ibio, Inc.	2 Q	-	-	-	-
Intercept Pharmaceuticals, Inc.	2 Q	98.36 %	-	66.21 %	-
Immune Design Corp.	2 Q	81.46 %	-	-	-
Immunogen Inc	2 Q	-	-	-	-
Imprimis Pharmaceuticals, Inc.	2 Q	59.97 %	24.29 %	12.31 %	-
Immune Pharmaceuticals Inc	2 Q	-	-	-	-
Immunocellular Therapeutics, Ltd.	2 Q	-	-	-	-
Innocoll Holdings Plc	1 Q	-	-	-	-
Insmed Inc	2 Q	-	-	-	-
Insite Vision Inc	0 Q	-	-	-	-
Insys Therapeutics, Inc.	2 Q	84.68 %	-	57.32 %	-
Intellipharmaceutics International Inc.	3 Q	89.05 %	-	-	-
Innovation Pharmaceuticals Inc.	2 Q	-	-	-	-
Impax Laboratories, Llc	1 Q	21.27 %	-	-	-
Ironwood Pharmaceuticals Inc	2 Q	94.99 %	-	-	-
Ionis Pharmaceuticals Inc	2 Q	-	-	-	-
Intra-cellular Therapies, Inc.	2 Q	-	-	-	-
Rocket Pharmaceuticals, Inc.	2 Q	-	-	-	-
Jaguar Health, Inc.	2 Q	31.21 %	-	-	-
Jazz Pharmaceuticals Plc	2 Q	-	18.45 %	6.38 %	16.02 %
Johnson & Johnson	2 Q	66.75 %	18.98 %	14.07 %	2.11 %
Juniper Pharmaceuticals Inc	2 Q	40.45 %	-	4.97 %	-
Kalobios Pharmaceuticals Inc	0 Q	-	-	-	-
Kalvista Pharmaceuticals, Inc.	2 Q	-	-	-	-
Humanigen, Inc	2 Q	-	-	-	-
Kadmon Holdings, Inc.	2 Q	44.01 %	-	-	-
Keryx Biopharmaceuticals Inc	2 Q	67.27 %	-	-	-
Keyuan Petrochemicals, Inc.	0 Q	-	-	-	-
Kindred Biosciences, Inc.	2 Q	-	-	-	-
Kempharm, Inc	2 Q	-	-	-	-
Karyopharm Therapeutics Inc.	2 Q	-	-	-	-
China Shenghuo Pharmaceutical Holdings Inc	0 Q	-	-	-	-
Kura Oncology, Inc.	2 Q	-	-	-	-
Kythera Biopharmaceuticals Inc	0 Q	-	-	-	-
Lannett Co Inc	2 Q	38.93 %	-	-	4.83 %
Luckycom Pharmaceuticals Inc.	4 Q	-	-	-	-
Lifevantage Corp	2 Q	85.06 %	5.54 %	5 %	31.34 %
Ligand Pharmaceuticals Inc	2 Q	95.07 %	81.25 %	-	25.18 %
Lilly Eli & Co	1 Q	72.43 %	21.36 %	-	8.12 %
Loxo Oncology, Inc.	2 Q	-	-	-	-
Lipocine Inc.	2 Q	-	-	-	-
Lexicon Pharmaceuticals, Inc.	2 Q	93.91 %	-	-	-
Merrimack Pharmaceuticals Inc	2 Q	-	-	-	567.46 %
Mabcure Inc.	0 Q	-	-	-	-
Moleculin Biotech, Inc.	4 Q	-	-	-	-
Seres Therapeutics, Inc.	2 Q	-	-	-	-
Medicines Co	2 Q	-	-	-	-
Medivation, Inc.	0 Q	-	-	-	-
Mei Pharma, Inc.	2 Q	-	-	-	-
Macrogenics Inc	2 Q	-	-	-	-
Mmrglobal, Inc.	0 Q	-	-	-	-
Mallinckrodt Plc	2 Q	50.18 %	2.47 %	-	27.19 %
Mannkind Corp	2 Q	-	-	-	-
Medicinova Inc	2 Q	-	-	-	-
Merck & Co., Inc.	2 Q	67.35 %	16.4 %	-	3.92 %
Marinus Pharmaceuticals Inc	2 Q	-	-	-	-
Mirati Therapeutics, Inc.	1 Q	-	-	-	-
Mast Therapeutics, Inc.	0 Q	-	-	-	-
Molecular Templates, Inc.	2 Q	-	-	-	24.68 %
Mylan N.v.	2 Q	34.27 %	1.34 %	-	6.73 %
Myos Rens Technology Inc.	2 Q	29.55 %	-	-	-
Myovant Sciences Ltd.	2 Q	-	-	-	-
Natures Sunshine Products Inc	2 Q	73.4 %	-	5.03 %	-
Nabriva Therapeutics Plc	2 Q	-	-	-	-
Novabay Pharmaceuticals, Inc.	2 Q	82.86 %	-	-	-
Neos Therapeutics, Inc.	2 Q	38.51 %	-	-	-
Evofem Biosciences, Inc.	2 Q	-	-	-	-
Neptune Technologies & Bioressources Inc.	1 Q	-	-	-	10.79 %
Minerva Neurosciences, Inc.	2 Q	-	-	-	-
China Nuokang Bio-pharmaceutical Inc.	0 Q	-	-	-	-
Nektar Therapeutics	2 Q	99.49 %	89.31 %	80.57 %	172.71 %
Newlink Genetics Corp	4 Q	-	-	-	-
Novan, Inc.	1 Q	-	-	-	-
Inergetics Inc	0 Q	-	-	-	-
Nephrogenex, Inc.	0 Q	-	-	-	-
Inspyr Therapeutics, Inc.	3 Q	-	-	-	-
Intec Pharma Ltd.	2 Q	-	-	-	-
Neurotrope, Inc.	2 Q	-	-	-	-
Nexvet Biopharma Plc	1 Q	-	-	-	-
Novelion Therapeutics Inc.	0 Q	-	-	-	-
Nivalis Therapeutics, Inc.	2 Q	-	-	-	-
Novelos Therapeutics, Inc.	0 Q	-	-	-	-
Novartis Ag	2 Q	-	86.55 %	-	-
Northwest Biotherapeutics Inc	2 Q	-	-	-	-
Northwest Biotherapeutics Inc	0 Q	-	-	-	-
Ocera Therapeutics, Inc.	3 Q	-	-	-	-
Ocular Therapeutix, Inc.	2 Q	76.39 %	-	-	-
Oragenics Inc	2 Q	-	-	-	-
Ohr Pharmaceutical Inc	2 Q	-	-	-	-
Oncomed Pharmaceuticals Inc	1 Q	-	-	10.8 %	-
Omeros Corp	2 Q	92.99 %	-	-	-
Oncosec Medical Inc	1 Q	-	-	-	-
Onconova Therapeutics, Inc.	2 Q	-	-	-	-
Ophthotech Corp.	2 Q	-	-	-	480.69 %
Opko Health, Inc.	2 Q	49.03 %	-	-	-
Acer Therapeutics Inc.	3 Q	-	-	-	-
Orexigen Therapeutics, Inc.	3 Q	78.64 %	-	47.15 %	-
Oramed Pharmaceuticals Inc.	2 Q	86.06 %	-	61.26 %	89.84 %
Oragenics Inc	0 Q	-	-	-	-
Bioblast Pharma Ltd.	0 Q	-	-	-	-
Otonomy, Inc.	1 Q	9.63 %	-	-	-
Ovascience, Inc.	2 Q	-	-	-	-
Ovid Therapeutics Inc.	2 Q	-	-	-	-
Phibro Animal Health Corp	2 Q	31.88 %	10.44 %	-	36.64 %
Prestige Brands Holdings, Inc.	2 Q	55.37 %	31.86 %	0.68 %	34.73 %
Puma Biotechnology, Inc.	2 Q	82.6 %	-	6.2 %	-
Pacira Pharmaceuticals, Inc.	2 Q	75.13 %	3.05 %	89.54 %	-
Processa Pharmaceuticals, Inc.	2 Q	-	-	-	-
Aratana Therapeutics, Inc.	2 Q	73.41 %	-	-	-
Pfizer Inc	2 Q	78.35 %	28.81 %	-	34.23 %
Pfenex Inc.	2 Q	77.95 %	-	-	-
Progenics Pharmaceuticals Inc	2 Q	-	-	-	-
Pharmathene, Inc	1 Q	-	-	-	234.38 %
Peak Pharmaceuticals, Inc.	2 Q	-	-	-	-
Plx Pharma Inc.	2 Q	-	-	-	43.4 %
Pozen Inc	0 Q	-	-	-	-
Propanc Biopharma, Inc.	1 Q	-	-	-	-
Avid Bioservices, Inc.	2 Q	9.47 %	-	-	-
Perrigo Co Plc	2 Q	39.7 %	3.05 %	-	3.86 %
Prophase Labs, Inc.	1 Q	11.02 %	-	-	246.32 %
Prothena Corp Plc	2 Q	-	-	-	-
Paratek Pharmaceuticals, Inc.	2 Q	-	-	-	-
Protect Pharmaceutical Corp	1 Q	-	-	-	-
Protalex Inc	3 Q	-	-	-	-
Proto Script Pharmaceutical Corp	3 Q	84.84 %	-	-	-
Ptc Therapeutics, Inc.	2 Q	96.26 %	-	-	-
Patheon N.v.	1 Q	29.11 %	5.71 %	-	-
Pain Therapeutics Inc	2 Q	-	-	-	-
Portola Pharmaceuticals Inc	2 Q	73.77 %	-	-	-
Palatin Technologies Inc	2 Q	-	57.27 %	59.48 %	187.17 %
Pernix Therapeutics Holdings, Inc.	3 Q	73.86 %	15.72 %	31.88 %	-
Provectus Biopharmaceuticals, Inc.	2 Q	-	-	-	-
Phaserx, Inc.	3 Q	-	-	-	95.89 %
Novelion Therapeutics Inc.	3 Q	-	-	-	-
Uniqure N.v.	1 Q	-	-	-	-
Ultragenyx Pharmaceutical Inc.	2 Q	98.9 %	-	-	-
Ra Pharmaceuticals, Inc.	2 Q	-	-	-	-
Rock Creek Pharmaceuticals, Inc.	0 Q	-	-	-	-
Redhill Biopharma Ltd.	2 Q	52.85 %	-	-	-
Radius Health, Inc.	2 Q	92.03 %	-	-	-
Dr Reddys Laboratories Ltd	1 Q	36.74 %	4.73 %	-	7.78 %
Regeneron Pharmaceuticals Inc	1 Q	95.42 %	31.62 %	13.68 %	23.51 %
Reliv International Inc	2 Q	72.15 %	-	-	-
Recro Pharma, Inc.	1 Q	46.32 %	-	-	-
Reata Pharmaceuticals Inc	1 Q	-	12.6 %	-	-
Regulus Therapeutics Inc.	2 Q	-	-	-	-
Rigel Pharmaceuticals Inc	1 Q	-	-	-	-
Relypsa Inc	0 Q	-	-	-	-
Rexahn Pharmaceuticals, Inc.	2 Q	-	-	-	-
Rosetta Genomics Ltd.	4 Q	24.42 %	-	-	385.86 %
Raptor Pharmaceutical Corp	0 Q	-	-	-	-
Retrophin, Inc.	2 Q	97.15 %	-	68.19 %	-
Ritter Pharmaceuticals Inc	2 Q	-	-	-	-
Revance Therapeutics, Inc.	2 Q	-	-	-	-
Ignyta, Inc.	3 Q	-	-	-	-
Rxi Pharmaceuticals Corp	2 Q	-	-	-	-
Sage Therapeutics, Inc.	2 Q	-	-	-	-
Spring Bank Pharmaceuticals, Inc.	2 Q	-	-	-	-
Sciclone Pharmaceuticals Inc	2 Q	-	27.39 %	35.9 %	19.1 %
Sucampo Pharmaceuticals, Inc.	3 Q	71.54 %	16.92 %	-	-
Scynexis Inc	2 Q	-	-	-	-
Sagent Pharmaceuticals, Inc.	0 Q	-	-	-	-
Signpath Pharma, Inc.	0 Q	-	-	-	-
Synergy Pharmaceuticals, Inc.	1 Q	56.86 %	-	-	-
Shire Plc	2 Q	71.72 %	15.7 %	-	13.49 %
Shire Plc	0 Q	-	-	-	-
Shuttle Pharmaceuticals, Inc.	3 Q	-	-	-	-
Siga Technologies Inc	0 Q	-	-	-	-
Siga Technologies Inc	2 Q	-	-	-	-
Sunset Island Group, Inc	2 Q	-	-	-	-
Skystar Bio-pharmaceutical Co	0 Q	-	-	-	-
Summit Therapeutics Plc	2 Q	64.53 %	70.21 %	-	-
Sibannac, Inc.	1 Q	-	-	-	-
Sunesis Pharmaceuticals Inc	1 Q	-	-	-	-
Madrigal Pharmaceuticals, Inc.	1 Q	-	-	-	-
Sophiris Bio Inc.	2 Q	-	-	-	-
Spectrum Pharmaceuticals Inc	2 Q	72.67 %	56.87 %	-	-
Sarepta Therapeutics, Inc.	1 Q	-	-	-	-
Sierra Oncology, Inc.	2 Q	-	-	-	-
Steadymed Ltd.	2 Q	-	-	-	97.56 %
Stemline Therapeutics Inc	1 Q	-	-	-	-
Supernus Pharmaceuticals Inc	2 Q	96.3 %	30.88 %	-	27.49 %
Sinovac Biotech Ltd	4 Q	88.39 %	21.05 %	29.81 %	20.72 %
Savara Inc.	2 Q	-	-	-	-
Growblox Sciences, Inc.	0 Q	-	-	-	-
Synlogic, Inc.	2 Q	-	-	-	-
Synthetic Biologics, Inc.	2 Q	-	-	-	-
Syros Pharmaceuticals, Inc.	2 Q	-	-	-	-
Taro Pharmaceutical Industries Ltd	1 Q	70.03 %	31.74 %	-	9.5 %
Theravance Biopharma, Inc.	2 Q	-	-	-	-
Teva Pharmaceutical Industries Ltd	2 Q	43.84 %	-	-	-
Threshold Pharmaceuticals Inc	2 Q	-	38.17 %	-	-
Innoviva, Inc.	2 Q	-	84.39 %	89.57 %	-
Tokai Pharmaceuticals Inc	1 Q	-	-	-	-
Tetralogic Pharmaceuticals Corp	0 Q	-	-	-	-
Tonix Pharmaceuticals Holding Corp.	2 Q	-	-	-	-
Tocagen Inc	2 Q	-	-	-	-
Tianyin Pharmaceutical Co., Inc.	0 Q	-	-	-	-
Tapimmune Inc.	2 Q	-	-	-	-
Trevena Inc	2 Q	-	-	-	-
Transcept Pharmaceuticals Inc	0 Q	-	-	-	-
Tesaro, Inc.	2 Q	73.76 %	-	-	-
Titan Pharmaceuticals Inc	2 Q	97.38 %	-	-	-
Tetraphase Pharmaceuticals Inc	2 Q	-	-	-	-
Therapeuticsmd, Inc.	2 Q	87.93 %	-	-	-
Shineco, Inc.	2 Q	30.4 %	-	35.46 %	10.45 %
Tyme Technologies, Inc.	2 Q	-	-	-	-
United Therapeutics Corp	2 Q	86.12 %	38.9 %	-	31.3 %
Vaccinogen Inc	0 Q	-	-	-	-
Viking Therapeutics, Inc.	2 Q	-	-	-	-
Vanda Pharmaceuticals Inc.	2 Q	88.99 %	9.74 %	-	0.68 %
Vertex Pharmaceuticals Inc	2 Q	86.12 %	27.42 %	-	10.88 %
Bausch Health Companies Inc.	2 Q	72.09 %	-	-	-
Versartis, Inc.	1 Q	-	-	-	-
Verastem, Inc.	1 Q	-	-	-	-
Vitae Pharmaceuticals, Inc	0 Q	-	-	-	-
Vital Therapies Inc	2 Q	-	-	-	-
Vtv Therapeutics Inc.	2 Q	-	-	-	-
Vivus Inc	2 Q	78.03 %	-	-	-
World Health Energy Holdings, Inc.	4 Q	-	-	-	-
Wuxi Pharmatech (cayman) Inc.	0 Q	-	-	-	-
Xbiotech Inc.	2 Q	-	-	-	-
Xenon Pharmaceuticals Inc.	2 Q	-	-	-	-
Xencor Inc	2 Q	-	-	-	-
Xenoport Inc	0 Q	-	-	-	-
Xoma Corp	2 Q	-	-	-	314.56 %
Zafgen, Inc.	2 Q	-	-	-	-
Zogenix, Inc.	2 Q	-	-	14.58 %	-
Zosano Pharma Corp	2 Q	-	-	-	-
Zs Pharma, Inc.	0 Q	-	-	-	-
Zoetis Inc.	2 Q	68.41 %	27 %	-	57.1 %
Zynerba Pharmaceuticals, Inc.	2 Q	-	-	-	-

Profitability

Major Pharmaceutical Preparations Industry
Gross margin improved to 65.35 % in 3. Quarter 2018 from 59.29 % in previous quarter, now Ranking #23 and ranking within sector #2.
Net margin for Major Pharmaceutical Preparations Industry is 15.58 % above industry average.

More on Major Pharmaceutical Preparations Industry Profitability

Return on equity in 3. Quarter 2018 was 2.2 %, Total Ranking # and ranking within sector #.

More on Major Pharmaceutical Preparations Industry Cash flow
More on Major Pharmaceutical Preparations Industry ROE

You need to upgrade your Flash Player

• Cash Flow Margin

Financial Strength

Mgmt. Effectiveness

Cardiovascular Segment
Revenues		Income
-	-	-	-
Y/Y	Q/Q	Y/Y	Q/Q

Neuroscience Segment
Revenues		Income
-	-	-	-
Y/Y	Q/Q	Y/Y	Q/Q

Anti-Infective Segment
Revenues		Income
14.75%	-7.45%	23.14%	-12.12%
Y/Y	Q/Q	Y/Y	Q/Q

Respiratory Segment
Revenues		Income
-	-	-	-
Y/Y	Q/Q	Y/Y	Q/Q

Arthritis & Pain Segment
Revenues		Income
24.3%	7.73%	-	-
Y/Y	Q/Q	Y/Y	Q/Q

Urology Segment
Revenues		Income
-	-	-	-
Y/Y	Q/Q	Y/Y	Q/Q

Oncology Segment
Revenues		Income
9.97%	1.68%	-	-
Y/Y	Q/Q	Y/Y	Q/Q

Endocrine Segment
Revenues		Income
-34.8%	-30.47%	-	-
Y/Y	Q/Q	Y/Y	Q/Q

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar PMCB's Report PMCB's News PMCB's Revenue Growth PMCB's Description Fundamentals Charts & Quotes PMCB's ROI Suppliers Competition Customers & Markets PMCB's Profitability PMCB's Growth PMCB's PE PMCB's Dividends PMCB's Quick Ratio	Screening Share Price Performance Growth Rates Ranking Profitability Valuation Dividend Financial Strength Efficiency Ranking Expectations Mgmnt. Effectivness	Glossary Financial Terms Technical Analysis Fundamental Analysis Energy Terms Manufacturing Terms Transportation Terms Health Care Insurance Terms Economy Terms Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071